ASX:SSM
ASX:SSMConstruction

Service Stream (ASX:SSM) Is Up 13.2% After Securing A$1.6 Billion Defence Contract

Service Stream announced it has secured a long-term base services contract with the Australian Department of Defence valued at approximately A$1.6 billion, covering 113 defence sites and training facilities in South Australia and the Northern Territory for an initial six years with options to extend to ten years. This agreement marks a significant move into defence for Service Stream, broadening its operations and providing a stable, government-backed revenue stream while supporting the...
ASX:BGL
ASX:BGLMetals and Mining

Bellevue Gold (ASX:BGL): Assessing Valuation as New Director and Key Summit Spotlight Shift Focus

There has been a flurry of conversation lately about Bellevue Gold (ASX:BGL), and it is not hard to see why. The company has just appointed Leigh Junk, a mining veteran with a proven record of steering teams through seismic industry changes, to its board as Independent Non-Executive Director. In addition, Bellevue Gold is scheduled to present at the upcoming Precious Metals Summit in Beaver Creek, a headline event where investors, analysts, and sector insiders will be watching closely for...
ASX:PNR
ASX:PNRMetals and Mining

Pantoro Gold (ASX:PNR): Evaluating Valuation as 2025 Beaver Creek Summit Sparks Investor Interest

Pantoro Gold (ASX:PNR) is stepping into the spotlight as it prepares to present at the 2025 Precious Metals Summit in Beaver Creek, an event known for connecting mining companies with a wide audience of investors and industry leaders. For those already holding shares or eyeing the gold sector, this conference could offer important signals about Pantoro Gold’s direction, growth plans and outlook, making it a talking point across investor circles. The company has seen its share price climb 2.5...
ASX:AYA
ASX:AYAHealthcare Services

How Investors May Respond To Artrya (ASX:AYA) Raising A$80 Million for US FDA-Approved Salix Expansion

Artrya recently completed a major capital raise of A$80 million through follow-on equity offerings, aimed at supporting its US expansion after securing FDA approval for its AI-driven Salix coronary plaque detection device. This development underscores growing investor confidence in Artrya’s efforts to commercialize advanced medical technology in the lucrative US healthcare market. We'll explore how the FDA-approved rollout of Salix in the US contributes to Artrya's broader investment...
ASX:3PL
ASX:3PLConsumer Services

ASX Penny Stock Highlights For September 2025

Australian shares have been striving to align with Wall Street's bullish trends, as evidenced by the ASX 200 futures showing a positive uptick heading into Friday. This momentum comes amid broader market gains in the U.S., where indices like the S&P 500 and Dow Jones have reached new highs despite recent economic data challenges. In this context, penny stocks—though often considered niche investments—continue to offer intriguing opportunities for investors willing to explore beyond mainstream...